The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals
Peter Ehrenkranz, Sydney Rosen, Andrew Boulle, Jeffrey W. Eaton, Nathan Ford, Matthew P. Fox, Anna Grimsrud, Brian Rice, Izukanji Sikazwe, Charles B. Holmes
Abstract
Antiretroviral therapy (ART) for human immunodeficiency virus (HIV) prevents illness and death from HIV disease and transmission of HIV infection. To encourage global scale-up of ART, the Joint UN Program on HIV/AIDS (UNAIDS) issued the "95-95-95" targets for the HIV "cascade of care." These targets state that by 2030, 95% of individuals living with HIV will know their HIV status, 95% of people with diagnosed HIV infection will receive ART, and 95% of those taking ART will have achieved suppression of the virus.
Topics & Concepts
Revolving doorHuman immunodeficiency virus (HIV)MedicineEnvironmental healthService delivery frameworkFamily medicineVirologyService (business)BusinessGeographyMarketingArchaeologyHIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskSex work and related issues